Another dose of vaccine likely to be needed with 12 months: Pfizer CEO

Pfizer Chief Executive Officer Albert Bourla said people will likely need a third dose of the Pfizer/BioNTech Covid-19 vaccine within 12 months of getting fully inoculated

Pfizer Vaccine, Coronavirus vaccine
Photo: Shutterstock
IANS Washington
1 min read Last Updated : Apr 16 2021 | 10:26 AM IST

Pfizer Chief Executive Officer Albert Bourla said people will likely need a third dose of the Pfizer/BioNTech Covid-19 vaccine within 12 months of getting fully inoculated.

Bourla told CNBC News on Thursday that it is possible people will need to get vaccinated against the coronavirus annually, reports Xinhua news agency.

"We need to see what would be the sequence, and for how often we need to do that, that remains to be seen," he told CNBC.

"A likely scenario is that there will be likely a need for a third dose, somewhere between six and 12 months and then from there, there will be an annual re-vaccination, but all of that needs to be confirmed. And again, the variants will play a key role," he said.

Pfizer said earlier this month that its Covid-19 vaccine was more than 91 per cent effective at protecting against the coronavirus, and more than 95 per cent effective against severe disease up to six months after the second dose.

The data was based on more than 12,000 vaccinated participants.

Researchers are still working on how long protection against the virus lasts once individuals has been fully vaccinated.

--IANS

ksk/

 

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccinePfizer

First Published: Apr 16 2021 | 10:20 AM IST

Next Story